Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Alcidion.
RELATED STOCKHEAD STORIES
Experts
Dr Boreham’s Crucible: Can this Aussie medtech rise as it lifts a cumbersome NHS into the digital age?
Health & Biotech
Check Up: Europe delivers blow to Alzheimer’s research; and recent ASX health stock winners
News
ASX Small Caps Lunch Wrap: We’re not living in a Materials world anymore. At least not today
Health & Biotech
ASX Health Stocks: Alcidion soars as it helps bring UK patient records into digital age
Health & Biotech
ASX Health Stocks: Immutep gets crucial therapy trial clearance; Alcidion wins $4m deal
News
Market Highlights: Records tumble, Powell to testify, and 5 ASX small caps to watch today
News
In Case You Missed It: A happy pharma debutante, plus positive news for a bunch of explorers
Health & Biotech
ASX Health Stocks: The secret is out – Chemist Warehouse plans ASX listing via Sigma healthcare merger
Health & Biotech
ScoPo’s (actually Wilkie’s) Powerplays: Inoviq soars on clinical data for breast cancer test
Health & Biotech
ASX Health Stocks: Neurotech gets approval to treat children patients until they are 20 years old
News
Market Highlights: NY and London closed; expert warns of downside correction in US stocks
Tech
The Nasdaq has just entered a new bull market – is the tide also turning for ASX Tech stocks?
Experts
CRITERION: In a wounded tech sector, these 10 stocks are tipped for a profitable year ahead
Health & Biotech
ASX Health Stocks: Most biotechs are still chasing maiden revenue, but here’s a few healthcare stocks with strong earnings
Health & Biotech
ASX Health Stocks: Kazia gets published in renowned Journal, Cochlear rejects ACCC’s claims
Experts
MoneyTalks: Dean Fergie’s top 3 contrarian tech stock picks
Health & Biotech
